How we are empowering Daiichi Sankyo with End-to-end Analytics to achieve their goal of becoming a global pharmaceutical innovator by 2025. Providing extensive information from markets about customers, products and the performance of the field
Force. Starting from very heterogeneous applications in the individual countries, which were outdated due to the QlikView technology, a modern and centrally coordinated solution was created on the basis of Qlik Sense, which greatly improves and simplifies the control of sales activities in particular.
3 KPIS/Milesstones of the project:
- Improvements in usability, in particular the integration of country-specific requirements and market structures in an overarching cross-national European view.
- Implementation of a dashboard that connects existing and new data source.
- Track and control the market launch of new products in real time.
Main Benefits:
- Creation of an integrated solution with where management can track national and international targets and the pharmaceutical representative can view his personal target visit quota on site with the customer.
- The corresponding applications and dashboards only display the information that is relevant for the respective user.
- Daiichi has now a permanent partner in celver/SDG Group, which will take care of all European projects in the area of Commercial Excellence in a structured way and drive them forward.